Sensorineural Hearing Loss following Imatinib (Gleevec) Administration

Abstract

Keywords

imatinib hearing loss ototoxicity nephrogenic systemic fibrosis

Get full access to this article

View all access options for this article.

References

Kay

High

. Imatinib mesylate treatment of nephrogenic systemic fibrosis. Arthritis Rheum. 2008;58:2543-2548.

Attili

Bapsy

Anupama

Lokanatha

. Irreversible sensorineural hearing loss due to imatinib. Leuk Res. 2008;32:991-992.

Janssen

Berendse

Schuurhuis

Merle

Ossenkoppele

. A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment. Am J Hematol. 2009;84:679-682.

Fritzsch

Pirvola

Ylikoski

. Making and breaking the innervation of the ear: neurotrophic support during ear development and its clinical implications. Cell Tissue Res. 1999;295:369-382.

Petit

. Genes responsible for human hereditary deafness: symphony of a thousand. Nat Genet. 1996;14:385-391.